2001
DOI: 10.1590/s0074-02762001000400014
|View full text |Cite
|
Sign up to set email alerts
|

Typing and susceptibility to penicillin of Neisseria meningitidis isolated from patients in Cuba (1993-1999)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
1

Year Published

2005
2005
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 9 publications
(6 reference statements)
0
5
0
1
Order By: Relevance
“…P1. 19.15 has been the most frequently identified, using ELISA [ 14 ]. It is likely due to the fact that VA-MEMGOC B-C prevents the disease, but does not eliminate the nasopharyngeal carriage [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…P1. 19.15 has been the most frequently identified, using ELISA [ 14 ]. It is likely due to the fact that VA-MEMGOC B-C prevents the disease, but does not eliminate the nasopharyngeal carriage [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…Those studies that are available indicate that serogroup B was the most prevalent endemic disease serogroup pre-2000 in several countries in Latin America, including Colombia (78% of isolates identified between 1994 and 2006) [39], Chile (over 90% of isolates identified between 1992 and 1993) [40], Brazil [21] and Uruguay [19, 41]. However, although the incidence of MD in Cuba after the introduction of vaccination remained at <1·4 cases/100 000 population per year from 1992 onwards, a sample of 111 isolates tested from subsequent years indicated that serogroup B, particularly the B:4:P1.15 serotype, remained the dominant cause of disease [32]. …”
Section: Introductionmentioning
confidence: 99%
“…This clone was associated with epidemic disease in Cuba, with a peak incidence of 14 cases/100 000 reported in 1983 [31]. The most prevalent strain in this outbreak was B:4:P1.19,15:L3,7,9, belonging to the ET5 type [32]. This strain was also important in epidemics in Brazil in the late 1980s [33, 34], and was identified as dominant in Brazil in the 1990s [35].…”
Section: Introductionmentioning
confidence: 99%
“…Among the other countries of Latin America, serogroup B has been predominant in Argentina [85] since 2001 and especially during the periods 1993-1995 and 2002-2005, causing about two-third of cases of infections [86], and in Colombia as resulted by the analysis performed on 434 isolates collected between 1994 and 2006 [87]. However, no data on meningitis epidemiology are available for this last country [10] and Cuba, which in 1983 experienced an outbreak caused by serogroup B wherein meningococcal disease reached the incidence of 14.4 cases per 100,000 population [88].…”
Section: Latin Americamentioning
confidence: 99%